Netherlands· NL-82bc7423e889

Rifadin, suspensie 20 mg/ml

A rifampicin product containing rifampicine, registered in Netherlands by Sanofi B.V.. The same ATC class is registered in 18 of our 19 countries.

ATC J04AB02

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about rifampicineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Rifampicin is registered in 18 of 19 countries.

Countries holding a registration under ATC J04AB02 (rifampicin), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
10 of them publish a price we can compare per daily dose

Search rifampicin products by name

Rifampicin · ATC J04AB02

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of rifampicin costs, country by country.

Normalised to the WHO defined daily dose (0.6 g), the median price runs from $0.92 in Italy to $6.35 in France — a ×6.9 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Rifampicin · price per daily dose (0.6 g)

USD · FX 28 Sept 2026

FR France$6.35
CH Switzerland$4.70
IT Italy$0.92

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: RIFAMPICINE
Manufacturer: Sanofi B.V.
Country: Netherlands (NL)
ATC code: J04AB02
ATC class: Rifampicin
Defined daily dose: 0.6 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
05766

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

444 interactions on record for rifampicin.

Graded by severity as the source publishes them — 144 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check rifampicin against other medicines How interaction checks work

Rifampicin · interactions on record

444 records

144 severe
173 moderate
14 minor
39 info

Most severe, free to view

RolapitantA04AD14severe
NaloxegolA06AH03severe
NaldemedineA06AH05severe
EluxadolineA07DA06severe

74 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Rifampicin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All rifampicin products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

Austria · Eremfat, Rifoldin
Belgium · Rifadine, Rifadine I. V.
Bulgaria · Тубоцин
Cyprus · Rifasynt, Syntoren
Czechia · Benemicin
Germany · Eremfat, Eremfat I.V.
Denmark · Rimactan
Spain · Rifaldin, Rimactán
Finland · Rimapen
France · Rifadine, Rifadine Iv
United Kingdom (Northern Ireland) · Rifadin, Rifampicin Generics Uk
Croatia · Rimactan
Hungary · Rifamed
Ireland · Rifadin, Rifadin Intravenous
Iceland · Rimactan
Italy · Rifadin
Lithuania · Benemicin
Luxembourg · Rifadine
Latvia · Benemicin
Malta · Rifampicyna Tzf
Norway · Rimactan
Poland · Rifampicyna Tzf
Portugal · Rifadin, Rimactán
Romania · Rifampicină Arena, Sinerdol
Sweden · Rimactan
Slovakia · Benemicin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/9561f8f9-0b17-4e90-8e15-a674abab39b2
GET /v1/drugs/9561f8f9-0b17-4e90-8e15-a674abab39b2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Suspensie voor oraal gebruik",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h05766_smpc.pdf",
  "strength": null,
  "atc_label": "Rifampicin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg05766",
  "excipients": [
    "AGAR (E 406)",
    "DIETHANOLAMINE (RI)",
    "KALIUMSORBAAT (E 202)",
    "METHYLPARAHYDROXYBENZOAAT (E 218)",
    "NATRIUMMETABISULFIET (E 223)",
    "POLYSORBAAT 80 (E 433)",
    "PROPYLPARAHYDROXYBENZOAAT",
    "RASPBERRY FLAVOUR NO. 5 (RI)",
    "SACCHAROIDE (E 954)",
    "SACCHAROSE",
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "RIFAMPICINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h05766.pdf",
  "authorised_at": "1969/10/16",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "05766",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about rifampicin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console